Treatment success for diabetic kidney disease (1)

16 Apr 2019


Clinical trial findings in The New England Journal of Medicine report that canagliflozin can reduce the risk of kidney and cardiac failure in patients with diabetes.

iNews


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story